Table 3.
Predicted drug repositioning candidates for Gaucher disease
| Drug Name | Original Indication | References |
|---|---|---|
| Framycetin | Aminoglycosides (Aminocyclitols) | [54] |
| Amikacin | Aminoglycosides (Aminocyclitols) | |
| Tobramycin | Aminoglycosides (Aminocyclitols) | |
| Gentamicin | Aminoglycosides (Aminocyclitols) | |
| Netilmicin | Aminoglycosides (Aminocyclitols) | |
| Neomycin | Aminoglycosides (Aminocyclitols) | |
| Kanamycin | Aminoglycosides (Aminocyclitols) | |
| Ribostamycin | Aminoglycosides (Aminocyclitols) | |
| Arbekacin | Aminoglycosides (Aminocyclitols) | |
| Acarbose | Alpha-glucosidase inhibitors | [56] |
| Miglitol | Alpha-glucosidase inhibitors | |
| Bimatoprost | Anti-hypertension | [57–59] |
| Aliskiren | Anti-hypertension | |
| Tacrolimus | Immunosuppressant | |
| Sirolimus | Immunosuppressant | |
| Everolimus | Immunosuppressant |